SCHEMBL24927680

SCHEMBL24927680

N#Cc1cccc(-c2c3ccccc3c(-c3ccccc3)c3ccccc23)c1-c1cccc(C#N)c1-n1c2ccccc2c2ccccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IMPDH2 P12268 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.34
HIF1A Q16665 1/20 0.34
HTR3A P46098 1/20 0.33
KMT2A Q03164 3/20 0.33
ALDH1A1 P00352 3/20 0.33
MEN1 O00255 2/20 0.33
MAPK14 Q16539 1/20 0.33
MAOA P21397 1/20 0.33
TSHR P16473 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
KDM4E B2RXH2 2/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
SSTR2 P30874 1/20 0.32
MAPT P10636 1/20 0.32
STAT3 P40763 1/20 0.32
PDK2 Q15119 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25744382 0.91 SMN1; SMN2 (0.33) IMPDH2SMN1; SMN2HIF1AHTR3AKMT2A
SCHEMBL24926891 0.91 SMN1; SMN2 (0.35) IMPDH2SMN1; SMN2HIF1AHTR3AKMT2A
SCHEMBL24927645 0.91 SMN1; SMN2 (0.35) IMPDH2SMN1; SMN2HIF1AHTR3AKMT2A
SCHEMBL24927632 0.90 SMN1; SMN2 (0.34) IMPDH2SMN1; SMN2HIF1AHTR3AKMT2A
SCHEMBL24927483 0.90 ESR2 (0.39) IMPDH2SMN1; SMN2HIF1AHTR3AKMT2A
SCHEMBL24927007 0.89 ESR2 (0.36) IMPDH2SMN1; SMN2HIF1AHTR3AKMT2A
SCHEMBL24927155 0.88 ESR2 (0.38) IMPDH2SMN1; SMN2HIF1AHTR3AKMT2A
SCHEMBL24927218 0.88 GABRG2 (0.33) IMPDH2SMN1; SMN2HIF1AHTR3AKMT2A
SCHEMBL24927187 0.87 ESR2 (0.37) IMPDH2SMN1; SMN2HIF1AHTR3AKMT2A
SCHEMBL24927241 0.87 GABRG2 (0.34) IMPDH2SMN1; SMN2HIF1AHTR3AMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230034532-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230034532-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME NR0B1, CRY1, CCNT1 IMPDH2 4268/4885SMN1; SMN2 3122/4885HIF1A 865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.